Duration of Diabetes and Hypoglycemia Rates in T2D Patients Treated with Insulin Glargine vs NPH Insulin

被引：0

|

作者：

Dailey, George

Aurand, Lisa A.

Garg, Satish K.

机构：

来源：

DIABETES | 2011年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2262-PO

引用

收藏

页码：A602 / A602

页数：1

相关论文

共 50 条

[1] Duration of diabetes and hypoglycaemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin
Dailey, G.
Aurand, L.
Garg, S.
[J]. DIABETOLOGIA, 2011, 54 : S262 - S262
[2] Insulin Glargine (GLAR) and NPH Insulin (NPH) in Real Life in Russia in Patients with Type 2 Diabetes (T2D)
Shestakova, Marina V.
Glinkina, Irina V.
[J]. DIABETES, 2009, 58 : A530 - A530
[3] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
Dailey, G. E.
Gao, L.
Aurand, L.
Garg, S. K.
[J]. DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
[4] Effect of Gender on Outcomes in Patients with T2D Treated with Insulin Glargine vs Comparators
Mcgill, Janet B.
Vlajnic, Aleksandra
Knutsen, Patricia Gaye
Recklein, Carol
Rimler, Michael S.
Fisher, Simon J.
[J]. DIABETES, 2011, 60 : A602 - A603
[5] Similar progression of diabetic retinopathy with glargine or NPH insulin in type 2 diabetes (T2D)
Rosenstock, Julio
Fonseca, Vivian
McGill, Janet
Riddle, Matthew
Halle, Jean-Pierre
Hramiak, Irene
Johnston, Peter
Davis, Matthew
[J]. DIABETES, 2008, 57 : A86 - A86
[6] Similar Hypoglycemia Duration with Once-Weekly Insulin Icodec vs. Insulin Glargine U100 in Insulin Naive or Experienced Patients with T2D
Silver, Robert J.
Asong, Marisse
Begtrup, Kamilla
Koefoed, Mette M.
Heller, Simon R.
Rosenstock, Julio
[J]. DIABETES, 2021, 70
[7] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
Rosenstock, J
Dailey, G
Massi-Benedetti, M
Fritsche, A
Lin, ZN
Salzman, A
[J]. DIABETES CARE, 2005, 28 (04) : 950 - 955
[8] Comparing efficiency of insulin glargine vs. NPH insulin in patients with type 2 diabetes
Kodela, B.
Petrovic, J.
Velickovic-Radovanovic, R.
Lilic, R.
Radenkovic, S.
Dedovic, I
[J]. VALUE IN HEALTH, 2007, 10 (06) : A254 - A254
[9] β-Cell-Relieving Effects of Basal Insulin Plus Metformin (MET) Treatment in Type 2 Diabetes (T2D) Patients (Pts) Using Insulin Glargine (GLA) or NPH Insulin (NPH)
Hohberg, Cloth
Larbig, Martin
Pfuetzner, Andreas
Roth, Werner
Forst, Thomas
[J]. DIABETES, 2009, 58 : A119 - A119
[10] Hypoglycemia and postprandial glucose are lower with insulin glargine versus NPH insulin in older type 2 diabetes patients
Fritsche, A
Dailey, G
Lin, Z
Murray, F
Häring, H
Rosenstock, J
[J]. GERONTOLOGIST, 2004, 44 : 221 - 221

← 1 2 3 4 5 →